Hikma Pharmaceuticals (HKMPY)
PNK: HKMPY
· Real-Time Price · USD
53.81
-1.74 (-3.13%)
At close: May 06, 2025, 2:10 PM
-3.13% (1D)
| Bid | 52.59 |
| Market Cap | 5.93B |
| Revenue (ttm) | 3.11B |
| Net Income (ttm) | 357.66M |
| EPS (ttm) | 3.22 |
| PE Ratio (ttm) | 16.71 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 54.97 |
| Volume | 32 |
| Avg. Volume (20D) | 405 |
| Open | 55.55 |
| Previous Close | 55.55 |
| Day's Range | 53.81 - 55.55 |
| 52-Week Range | 45.97 - 59.26 |
| Beta | 0.63 |
| Ex-Dividend Date | n/a |
About HKMPY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HKMPY
Website n/a
1 month ago · seekingalpha.com
Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call TranscriptHikma Pharmaceuticals PLC (OTCPK:HKMPF) Q2 2025 Q&A Earnings Call August 7, 2025 4:00 AM ET Company Participants Khalid Waleed Hosny Al Nabilsi - Chief Financial Officer Riad Ali Mishlawi - CEO & Dire...
